Cover Image
市場調查報告書

隱球菌腦膜炎:全球臨床實驗檢討

Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 319595
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
隱球菌腦膜炎:全球臨床實驗檢討 Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月17日 內容資訊: 英文 76 Pages
簡介

本報告提供隱球菌腦膜炎的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 隱球菌腦膜炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上隱球菌腦膜炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上隱球菌腦膜炎所佔的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

隱球菌腦膜炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • TTY Biopharm Company Limited
    • Novartis AG
    • Liposome Company, Inc
    • Alkermes Plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • St. George's University of London
    • University of Minnesota
    • University of Oxford
    • University of Zimbabwe-Parirenyatwa Clinical Research Center
    • Department of Biotechnology, India
    • French National Agency for Research on AIDS and Viral Hepatitis

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2425CTIDB

GlobalData's clinical trial report, "Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cryptococcal Meningitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cryptococcal Meningitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • TTY Biopharm Company Limited
      • Clinical Trial Overview of TTY Biopharm Company Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Liposome Company, Inc
      • Clinical Trial Overview of Liposome Company, Inc
      • Alkermes Plc
      • Clinical Trial Overview of Alkermes Plc
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • St. George's University of London
      • Clinical Trial Overview of St. George's University of London
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • University of Zimbabwe-Parirenyatwa Clinical Research Center
      • Clinical Trial Overview of University of Zimbabwe-Parirenyatwa Clinical Research Center
      • Department of Biotechnology, India
      • Clinical Trial Overview of Department of Biotechnology, India
      • French National Agency for Research on AIDS and Viral Hepatitis
      • Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by TTY Biopharm Company Limited, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Liposome Company, Inc, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Plc, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. George's University of London, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zimbabwe-Parirenyatwa Clinical Research Center, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Biotechnology, India, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014*

List of Figures

  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top